OCTANATE 500 and OCTANATE 1000 _ Public assessment summary report
OCTANATE 500 and OCTANATE 1000 _ Public assessment summary report
Utrogestan Vaginal 100 mg and 200 mg Soft capsules _ Public assessment summary report_Package label
Utrogestan Vaginal 100 mg and 200 mg Soft capsules _ Public assessment summary report_Package label
Utrogestan Vaginal 100 mg and 200 mg Soft capsules_SUMMARY OF PRODUCT CHARACTERISTICS
Utrogestan Vaginal 100 mg and 200 mg Soft capsules_SUMMARY OF PRODUCT CHARACTERISTICS
Minox 5, 50 mg ml, cutaneous solution_SUMMARY OF PRODUCT CHARACTERISTICS
Minox 5, 50 mg ml, cutaneous solution_SUMMARY OF PRODUCT CHARACTERISTICS
Minox 5, 50 mg ml, cutaneous solution_ Public assessment summary report_Package label
Minox 5, 50 mg ml, cutaneous solution_ Public assessment summary report_Package label
Delstrigo 100 mg 300 mg 245 mg film-coated tablets_ Public assessment summary report_Package label-1
Delstrigo 100 mg 300 mg 245 mg film-coated tablets_ Public assessment summary report_Package label-1
CELMANTIN 10 mg and 20 mg film-coated tablets_public assessment summary report_Package label
CELMANTIN 10 mg and 20 mg film-coated tablets_public assessment summary report_Package label-
Delstrigo100 mg 300 mg 245 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS
Delstrigo100 mg 300 mg 245 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS
CELMANTIN 10 mg and 20 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS
CELMANTIN 10 mg and 20 mg film-coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS
Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets Summary of product Characteristics
Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets Summary of product Characteristics